A vitamin as neuromodulator: ascorbate release into the extracellular fluid of the brain regulates dopaminergic and glutamatergic transmission

GV Rebec, RC Pierce - Progress in neurobiology, 1994 - Elsevier
5.1. Interaction with the dopaminergic system 5.1. 1. Dopamine receptor binding
experiments 5.1. 2. Behavioral and biochemical evidence 5.2. Interaction with the …

Brain dopamine receptors: a primer on their current status, basic and clinical

RJ Baldessarini, FI Tarazi - Harvard review of psychiatry, 1996 - Taylor & Francis
Recent progress in understanding the molecular biology and pharmacology of dopamine
receptors in mammalian brain has been remarkable and can serve as a basis for …

Loss of autoreceptor functions in mice lacking the dopamine transporter

SR Jones, RR Gainetdinov, XT Hu, DC Cooper… - Nature …, 1999 - nature.com
Autoreceptors provide an important inhibitory feedback mechanism for dopamine neurons
by altering neuronal functions in response to changes in extracellular levels of dopamine …

Biochemical and pharmacological studies on pramipexole, a potent and selective dopamine D2 receptor agonist

J Mierau, G Schingnitz - European journal of pharmacology, 1992 - Elsevier
Abstract Pramipexole (SND 919; 2-amino-4, 5, 6, 7-tetrahydro-6-propyl-amino-benzthiazole-
dihydrochloride) was tested for its agonistic activity at pre-and postsynaptic dopamine (DA) …

Spontaneous release of acetylcholine in striatum is preferentially regulated by inhibitory dopamine D2 receptors

P DeBoer, MJ Heeringa, ED Abercrombie - European journal of …, 1996 - Elsevier
The dose-related effects of the direct dopamine D2 receptor agonist quinpirole [trans-(−)-
4aR-4, 4a, 5, 6, 7, 8, 8a, 9-octahydro-5-propyl-1H-pyrazolo [3, 4-g] quinoline] on the …

Cerebrospinal fluid homovanillic acid predicts behavioral response to stimulants in 45 boys with attention deficit/hyperactivity disorder

FX Castellanos, J Elia, MJP Kruesi, WL Marsh… - …, 1996 - nature.com
Central dopaminergic activity has been assumed to play a role in the efficacy of stimulant
drugs in attention deficit/hyperactivity disorder (ADHD), although supporting evidence has …

Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist,(+)-S 14297: 1. Activation of postsynaptic D3 …

MJ Millan, JL Peglion, J Vian, JM Rivet, M Brocco… - … of Pharmacology and …, 1995 - ASPET
Using [125I]-iodosulpride as a radioligand, the novel naphthofurane,(+/-)-S 11566 [(+/-)-[7-
(N, N-dipropylamino)-5, 6, 7, 8-tetra-hydro-naphtho (2, 3b) dihydro, 2, 3-furane]) showed a …

Partial agonist properties of the antipsychotics SSR181507, aripiprazole and bifeprunox at dopamine D2 receptors: G protein activation and prolactin release

C Cosi, E Carilla-Durand, MB Assié, AM Ormiere… - European journal of …, 2006 - Elsevier
Dopamine D2 receptor antagonists induce hyperprolactinemia depending on the extent of
D2 receptor blockade. We compared the effects of the new antipsychotic agents SSR181507 …

Presynaptic receptors for dopamine, histamine, and serotonin

TJ Feuerstein - Pharmacology of Neurotransmitter Release, 2008 - Springer
Presynaptic receptors for dopamine, histamine and serotonin that are located on
dopaminergic, histaminergic and sertonergic axon terminals, respectively, function as …

Pramipexole, a dopamine D2 autoreceptor agonist, decreases the extracellular concentration of dopamine in vivo

AJ Carter, RE Müller - European journal of pharmacology, 1991 - Elsevier
Pramipexole (SND 919) is a dopamine D 2 autoreceptor agonist which is structurally related
to talipexole (B-HT 920), a potential antipsychotic agent. The aim of this study was to …